Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Genetic Technologies Receives Nasdaq Delisting Notification

Genetic Technologies Receives Nasdaq Delisting Notification

Mar 16, 2020
|
staff reporter

NEW YORK — Australian molecular diagnostics developer Genetic Technologies said last week that it received a notice that it is out of compliance with the Nasdaq's continued listing requirements and its shares face delisting.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Slow Release of Viral Sequence

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

Journals Raise Concerns Over Data Source

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Details From a Short Life

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

Genome Research Papers on Brain Expression, Inversion Assay, Polymorphic Yeast Centromeres

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

  2. Guardant Health Prices $315M Public Offering

  3. OpGen Expands Partnership with New York State Department of Health to Detect AMR Infections

  4. Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents

  5. Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.